Silverback Therapeutics stockholders elect directors, ratify auditor at 2022 annual meeting

ARS Pharmaceuticals, Inc.

Andrew Powell and Peter Thompson were elected Class II directors to serve until 2025 annual meeting.
Ernst & Young LLP was ratified as independent auditor for fiscal year ending Dec 31, 2022 with 99.8% of votes in favor.
Approximately 35.1 million shares were outstanding and entitled to vote as of April 11, 2022 record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.